sb 202190 has been researched along with Burns in 3 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Burns: Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoesel, LM | 3 |
| Mattar, AF | 1 |
| Arbabi, S | 3 |
| Niederbichler, AD | 3 |
| Ipaktchi, K | 3 |
| Su, GL | 3 |
| Westfall, MV | 1 |
| Wang, SC | 3 |
| Hemmila, MR | 3 |
| Mattar, A | 2 |
| Remick, DG | 1 |
| Vollmannshauser, S | 1 |
| Minter, RM | 1 |
3 other studies available for sb 202190 and Burns
| Article | Year |
|---|---|
Local wound p38 MAPK inhibition attenuates burn-induced cardiac dysfunction.
Topics: Animals; Burns; Imidazoles; Male; Myocardial Contraction; p38 Mitogen-Activated Protein Kinases; Pro | 2009 |
Topical p38MAPK inhibition reduces dermal inflammation and epithelial apoptosis in burn wounds.
Topics: Administration, Topical; Animals; Apoptosis; Burns; Chemokines, CXC; Cytokines; Dermatitis; Dose-Res | 2006 |
Topical p38 MAPK inhibition reduces bacterial growth in an in vivo burn wound model.
Topics: Administration, Topical; Animals; Burns; Chemokine CXCL2; Chemokines, CXC; Colony-Forming Units Assa | 2007 |